Republicans are closing in on their first legislative victory of the year, after two GOP Senators previously opposed to the tax plan got on board this weekend. But Democrats still have concerns. U.S. Congressman Ro Khanna (D-CA), who joined Cheddar before the most recent concessions were made, said the policies may benefit companies in his home district in the heart of Silicon Valley, but do little for Middle America. “We should create technology opportunity zones across America,” he said. “I think that the federal government in partnership with the private industry could do so much to bring the new industry to many of these communities.” Heading into the weekend, the future of tax reform seemed uncertain. Senator Marco Rubio (R-FL) was calling for a tax cut for working families. On Friday, though, he tweeted his support after the child tax credit was increased. Senator Bob Corker also changed his position after the tax on real estate earnings was reduced, a move that could benefit his own wallet. The Tennessee Republican reportedly made $7 million off his property investments last year. For full interview [click here](https://cheddar.com/videos/rep-ro-khanna-d-ca-congress-needs-to-step-up-to-spread-tech-development-across-the-u-s).

Share:
More In Politics
Skydio CEO On Russia-US Drone Collision
Adam Bry, co-founder and CEO of drone manufacturer Skydio, joined Cheddar News to discuss the company's latest funding round and the Russia-US drone collision.
Fed Set to Launch Digital Payments System Over the Summer
The Federal Reserve on Wednesday evening said its long-awaited digital payment system, the FedNow Service, will start operating in July. The service is designed to provide a national platform for financial institutions to settle payments in real-time and at lower cost. That could include large banks, payment processors, and the U.S. Treasury.
Long-Used US Abortion Pill Under Threat in Texas Lawsuit
A federal judge in Texas raised questions Wednesday about a Christian group's effort to overturn the decades-old U.S. approval of a leading abortion drug, in a case that could threaten the country's most common method for ending pregnancies.
Load More